Acquisition adds two new and rapidly growing segments to surgical portfolio
DALLAS–(BUSINESS WIRE)–DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced that it has completed the acquisition of total ankle and finger arthroplasty product lines from international medical technology company Stryker.
The acquisition includes the STAR® total ankle arthroplasty system, a preferred technology worldwide because of its deep and leading clinical outcomes research,1-9 along with Silicone, Surface Replacement (SR) and TACTYS® finger joint arthroplasty products, one of the world’s most comprehensive finger joint arthroplasty portfolios.
Ankle replacements in the U.S. more than doubled last year, in part because ankle implants are becoming the treatment of choice over fusion surgery.10 The STAR ankle is a mobile-bearing total ankle replacement in the U.S. market approved for uncemented use, making it a preferred choice for surgeons and patients who want to help restore mobility.
“Ankle and finger arthroplasty are two fast-growing arthroplasty segments, and this acquisition reflects DJO’s focus on providing market-leading solutions to meet the greater needs of surgeons and their patients,” said Brady Shirley, CEO of DJO®. “This expansion allows us to address a larger patient population and enhances our goal of helping patients return to an active lifestyle.”
STAR System
STAR is one of the first total ankle replacement systems in the market and carries a substantial amount of clinical data over many years demonstrating strong performance.1-9 Intended for use to replace a painful arthritic ankle joint due to osteoarthritis, post-traumatic arthritis or rheumatoid arthritis, STAR’s modular components and positional forgiveness allow for 225 patient-matched configurations with just one surgical technique.
Finger Joint Arthroplasty
The Silicone, Surface Replacement (SR) and TACTYS finger joint arthroplasty portfolio holds a leading global market position with a 20-year clinical history.
For more information, visit djoglobal.com/surgical.
About DJO®
DJO, a subsidiary of Colfax Corporation (NYSE: CFX), is a leading developer and distributor of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management. The Company’s extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation; enabling people around the world to regain or maintain their natural motion. For additional information about DJO, please visit www.DJOGlobal.com.
References
Contacts
Brittany Knudson
760-681-7785
Brittany.knudson@djoglobal.com
Charlotte, North Carolina--(Newsfile Corp. - January 8, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
RXNT celebrated the holiday season by giving back to four worthy, community-driven charities, all with…
TORRINGTON, Conn., Jan. 8, 2025 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic…
LAS VEGAS, Jan. 8, 2025 /PRNewswire/ -- Could this be the year your fitness goals…
Investment will advance Net Health's mission to provide patient-centric care by streamlining administrative processes for…
NEW YORK CITY, NEW YORK / ACCESSWIRE / January 8, 2025 / Black Book™ Market…